MicroRNAs: Novel Diagnostic and Prognostic Biomarkers in Atherosclerosis

Current Topics in Medicinal Chemistry

Volumn 13, Issue 13, 2013, Pages 1503-1517

  Siasos, Gerasimos ^a   Kollia, Christina ^a   Tsigkou, Vasiliki ^a   Basdra, Efthimia K ^a   Lymperi, Maria ^a   Oikonomou, Evangelos ^a   Kokkou, Eleni ^a   Korompelis, Porfyrios ^a   Papavassiliou, Athanasios G ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Atherosclerosis; Endothelial function; Inflammation; MicroRNAs

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; MICRORNA; MICRORNA 1; MICRORNA 100; MICRORNA 126; MICRORNA 127; MICRORNA 133; MICRORNA 133A; MICRORNA 143; MICRORNA 145; MICRORNA 146; MICRORNA 155; MICRORNA 181B; MICRORNA 200; MICRORNA 200B; MICRORNA 21; MICRORNA 210; MICRORNA 217; MICRORNA 221; MICRORNA 222; MICRORNA 223; MICRORNA 29A; MICRORNA 34A; MICRORNA 758; MICRORNA 92; RNA INDUCED SILENCING COMPLEX; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ANGIOGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BIOGENESIS; CELL CYCLE PROGRESSION; HUMAN; INFLAMMATION; LIPID METABOLISM; NONHUMAN; OXIDATIVE STRESS; REVIEW; THROMBOCYTE ACTIVATION;

ATHEROSCLEROSIS; BIOLOGICAL MARKERS; HUMANS; MICRORNAS; PROGNOSIS;

EID: 84881349465     PISSN: 15680266     EISSN: 18734294     Source Type: Journal    
DOI: 10.2174/15680266113139990099     Document Type: Review

References (184)

1. Papageorgiou, N.; Tousoulis, D.; Androulakis, E.; Siasos, G.; Briasoulis, A.; Vogiatzi, G.; Kampoli, A. M.; Tsiamis, E.; Tentolouris, C.; Stefanadis, C. The role of microRNAs in cardiovascular disease. Curr. Med. Chem., 2012, 19(16), 2605-2610.
2. Chen, W. J.; Yin, K.; Zhao, G. J.; Fu, Y. C.; Tang, C. K. The magic and mystery of microRNA-27 in atherosclerosis. Atherosclerosis, 2012, 222(2), 314-323.
3. Lee, R. C.; Feinbaum, R. L.; Ambros, V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell, 1993, 75(5), 843-854.
4. Friedman, R. C.; Farh, K. K.; Burge, C. B.; Bartel, D. P. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res., 2009, 19(1), 92-105.
5. Bartel, D. P.; Chen, C. Z. Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs. Nat. Rev. Genet., 2004, 5(5), 396-400.
6. Urbich, C.; Kuehbacher, A.; Dimmeler, S. Role of microRNAs in vascular diseases, inflammation, and angiogenesis. Cardiovasc. Res., 2008, 79(4), 581-588.
7. Nana-Sinkam, S. P.; Croce, C. M. MicroRNAs as therapeutic targets in cancer. Transl. Res., 2011, 157(4), 216-225.
8. Guay, C.; Roggli, E.; Nesca, V.; Jacovetti, C.; Regazzi, R. Diabetes mellitus, a microRNA-related disease? Transl. Res., 2011, 157(4), 253-264.
9. Kerr, T. A.; Korenblat, K. M.; Davidson, N. O. MicroRNAs and liver disease. Transl. Res., 2011, 157(4), 241-252.
10. Dai, R.; Ahmed, S. A. MicroRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseases. Transl. Res., 2011, 157(4), 163-179.
11. Small, E. M.; Olson, E. N. Pervasive roles of microRNAs in cardiovascular biology. Nature, 2011, 469(7330), 336-342.
12. Santovito, D.; Mezzetti, A.; Cipollone, F. MicroRNAs and atherosclerosis: new actors for an old movie. Nutr. Metab. Cardiovasc. Dis., 2012, 22(11), 937-943.
13. Siasos, G.; Tousoulis, D.; Michalea, S.; Oikonomou, E.; Kolia, C.; Kioufis, S.; Synetos, A.; Vlasis, K.; Papavassiliou, A. G.; Stefanadis, C. Biomarkers determining cardiovascular risk in patients with kidney disease. Curr. Med. Chem., 2012, 19(16), 2555-2571.
14. Tousoulis, D.; Oikonomou, E.; Siasos, G.; Chrysohoou, C.; Charakida, M.; Trikas, A.; Siasou, Z.; Limperi, M.; Papadimitriou, E. D.; Papavassiliou, A. G.; Stefanadis, C. Predictive value of biomarkers in patients with heart failure. Curr. Med. Chem., 2012, 19(16), 2534-2547.
15. Lagos-Quintana, M.; Rauhut, R.; Lendeckel, W.; Tuschl, T. Identification of novel genes coding for small expressed RNAs. Science, 2001, 294(5543), 853-858.
16. Rotllan, N.; Fernandez-Hernando, C. MicroRNA Regulation of Cholesterol Metabolism. Cholesterol., 2012, 2012, 847849.
17. Yi, R.; Qin, Y.; Macara, I. G.; Cullen, B. R. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev., 2003, 17(24), 3011-3016.
18. Chendrimada, T. P.; Gregory, R. I.; Kumaraswamy, E.; Norman, J.; Cooch, N.; Nishikura, K.; Shiekhattar, R. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature, 2005, 436(7051), 740-744.
19. Jaiswal, R.; Luk, F.; Gong, J.; Mathys, J. M.; Grau, G. E.; Bebawy, M. Microparticle conferred microRNA profiles--implications in the transfer and dominance of cancer traits. Mol. Cancer, 2012, 11, 37.
20. Gong, J.; Jaiswal, R.; Mathys, J. M.; Combes, V.; Grau, G. E.; Bebawy, M. Microparticles and their emerging role in cancer multidrug resistance. Cancer Treat. Rev., 2012, 38(3), 226-234.
21. Skog, J.; Wurdinger, T.; van Rijn, S.; Meijer, D. H.; Gainche, L.; Sena-Esteves, M.; Curry, W. T. Jr.; Carter, B. S.; Krichevsky, A. M.; Breakefield, X. O. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat. Cell Biol., 2008, 10(12), 1470-1476.
22. Reich, C. F. 3rd; Pisetsky, D. S. The content of DNA and RNA in microparticles released by Jurkat and HL-60 cells undergoing in vitro apoptosis. Exp. Cell Res., 2009, 315(5), 760-768.
23. Valadi, H.; Ekstrom, K.; Bossios, A.; Sjostrand, M.; Lee, J. J.; Lotvall, J. O. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol., 2007, 9(6), 654-659.
24. Hwang, H. W.; Wentzel, E. A.; Mendell, J. T. A hexanucleotide element directs microRNA nuclear import. Science, 2007, 315(5808), 97-100.
25. Kim, D. H.; Saetrom, P.; Snove, O. Jr.; Rossi, J. J. MicroRNAdirected transcriptional gene silencing in mammalian cells. Proc. Natl. Acad. Sci. U. S A., 2008, 105(42), 16230-16235.
26. Brennecke, J.; Stark, A.; Russell, R. B.; Cohen, S. M. Principles of microRNA-target recognition. PLoS. Biol., 2005, 3(3), e85.
27. Hutvagner, G.; Zamore, P. D. A microRNA in a multiple-turnover RNAi enzyme complex. Science, 2002, 297(5589), 2056-2060.
28. Lee, E. J.; Baek, M.; Gusev, Y.; Brackett, D. J.; Nuovo, G. J.; Schmittgen, T. D. Systematic evaluation of microRNA processing patterns in tissues, cell lines, and tumors. RNA, 2008, 14(1), 35-42.
29. Rayner, K. J.; Sheedy, F. J.; Esau, C. C.; Hussain, F. N.; Temel, R. E.; Parathath, S.; van Gils, J. M.; Rayner, A. J.; Chang, A. N.; Suarez, Y.; Fernandez-Hernando, C.; Fisher, E. A.; Moore, K. J. Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis. J. Clin. Invest., 2011, 121(7), 2921-2931.
30. Harris, T. A.; Yamakuchi, M.; Kondo, M.; Oettgen, P.; Lowenstein, C. J. Ets-1 and Ets-2 regulate the expression of microRNA-126 in endothelial cells. Arterioscler. Thromb. Vasc. Biol., 2010, 30(10), 1990-1997.
31. Huang, R. S.; Hu, G. Q.; Lin, B.; Lin, Z. Y.; Sun, C. C. MicroRNA-155 silencing enhances inflammatory response and lipid uptake in oxidized low-density lipoprotein-stimulated human THP-1 macrophages. J. Investig. Med., 2010, 58(8), 961-967.
32. Suarez, Y.; Wang, C.; Manes, T. D.; Pober, J. S. Cutting edge: TNF-induced microRNAs regulate TNF-induced expression of Eselectin and intercellular adhesion molecule-1 on human endothelial cells: feedback control of inflammation. J. Immunol., 2010, 184(1), 21-25.
33. Fang, Y.; Davies, P. F. Site-specific microRNA-92a regulation of Kruppel-like factors 4 and 2 in atherosusceptible endothelium. Arterioscler. Thromb. Vasc. Biol., 2012, 32(4), 979-987.
34. Weber, M.; Baker, M. B.; Moore, J. P.; Searles, C. D. MiR-21 is induced in endothelial cells by shear stress and modulates apoptosis and eNOS activity. Biochem. Biophys. Res. Commun., 2010, 393(4), 643-648.
35. Fleissner, F.; Jazbutyte, V.; Fiedler, J.; Gupta, S. K.; Yin, X.; Xu, Q.; Galuppo, P.; Kneitz, S.; Mayr, M.; Ertl, G.; Bauersachs, J.; Thum, T. Short communication: asymmetric dimethylarginine impairs angiogenic progenitor cell function in patients with coronary artery disease through a microRNA-21-dependent mechanism. Circ. Res., 2010, 107(1), 138-143.
36. Vasa-Nicotera, M.; Chen, H.; Tucci, P.; Yang, A. L.; Saintigny, G.; Menghini, R.; Mahe, C.; Agostini, M.; Knight, R. A.; Melino, G.; Federici, M. miR-146a is modulated in human endothelial cell with aging. Atherosclerosis, 2011, 217(2), 326-330.
37. Zhang, C. MicroRNA-145 in vascular smooth muscle cell biology: a new therapeutic target for vascular disease. Cell Cycle, 2009, 8(21), 3469-3473.
38. Cheng, Y.; Liu, X.; Yang, J.; Lin, Y.; Xu, D. Z.; Lu, Q.; Deitch, E. A.; Huo, Y.; Delphin, E. S.; Zhang, C. MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circ. Res., 2009, 105(2), 158-166.
39. Davis, B. N.; Hilyard, A. C.; Nguyen, P. H.; Lagna, G.; Hata, A. Induction of microRNA-221 by platelet-derived growth factor signaling is critical for modulation of vascular smooth muscle phenotype. J. Biol. Chem., 2009, 284(6), 3728-3738.
40. Minami, Y.; Satoh, M.; Maesawa, C.; Takahashi, Y.; Tabuchi, T.; Itoh, T.; Nakamura, M. Effect of atorvastatin on microRNA 221 / 222 expression in endothelial progenitor cells obtained from patients with coronary artery disease. Eur. J. Clin. Invest., 2009, 39(5), 359-367.
41. Nagalla, S.; Shaw, C.; Kong, X.; Kondkar, A. A.; Edelstein, L. C.; Ma, L.; Chen, J.; McKnight, G. S.; Lopez, J. A.; Yang, L.; Jin, Y.; Bray, M. S.; Leal, S. M.; Dong, J. F.; Bray, P. F. Platelet microRNA-mRNA coexpression profiles correlate with platelet reactivity. Blood, 2011, 117(19), 5189-5197.
42. Kondkar, A. A.; Bray, M. S.; Leal, S. M.; Nagalla, S.; Liu, D. J.; Jin, Y.; Dong, J. F.; Ren, Q.; Whiteheart, S. W.; Shaw, C.; Bray, P. F. VAMP8/endobrevin is overexpressed in hyperreactive human platelets: suggested role for platelet microRNA. J. Thromb. Haemost., 2010, 8(2), 369-378.
43. Fish, J. E.; Santoro, M. M.; Morton, S. U.; Yu, S.; Yeh, R. F.; Wythe, J. D.; Ivey, K. N.; Bruneau, B. G.; Stainier, D. Y.; Srivastava, D. miR-126 regulates angiogenic signaling and vascular integrity. Dev. Cell, 2008, 15(2), 272-284.
44. Fasanaro, P.; D'Alessandra, Y.; Di Stefano, V.; Melchionna, R.; Romani, S.; Pompilio, G.; Capogrossi, M. C.; Martelli, F. MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3. J. Biol. Chem., 2008, 283(23), 15878-15883.
45. Zhao, T.; Li, J.; Chen, A. F. MicroRNA-34a induces endothelial progenitor cell senescence and impedes its angiogenesis via suppressing silent information regulator 1. Am. J. Physiol. Endocrinol. Metab., 2010, 299(1), E110-116.
46. Zampetaki, A.; Kiechl, S.; Drozdov, I.; Willeit, P.; Mayr, U.; Prokopi, M.; Mayr, A.; Weger, S.; Oberhollenzer, F.; Bonora, E.; Shah, A.; Willeit, J.; Mayr, M. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ. Res., 2010, 107(6), 810-817.
47. Raitoharju, E.; Lyytikainen, L. P.; Levula, M.; Oksala, N.; Mennander, A.; Tarkka, M.; Klopp, N.; Illig, T.; Kahonen, M.; Karhunen, P. J.; Laaksonen, R.; Lehtimaki, T. miR-21, miR-210, miR-34a, and miR-146a/b are up-regulated in human atherosclerotic plaques in the Tampere Vascular Study. Atherosclerosis, 2011, 219(1), 211-217.
48. Castoldi, G.; Di Gioia, C. R.; Bombardi, C.; Catalucci, D.; Corradi, B.; Gualazzi, M. G.; Leopizzi, M.; Mancini, M.; Zerbini, G.; Condorelli, G.; Stella, A. MiR-133a regulates collagen 1A1: potential role of miR-133a in myocardial fibrosis in angiotensin IIdependent hypertension. J. Cell. Physiol., 2012, 227(2), 850-856.
49. Cipollone, F.; Felicioni, L.; Sarzani, R.; Ucchino, S.; Spigonardo, F.; Mandolini, C.; Malatesta, S.; Bucci, M.; Mammarella, C.; Santovito, D.; de Lutiis, F.; Marchetti, A.; Mezzetti, A.; Buttitta, F. A unique microRNA signature associated with plaque instability in humans. Stroke, 2011, 42(9), 2556-2563.
50. Esau, C.; Davis, S.; Murray, S. F.; Yu, X. X.; Pandey, S. K.; Pear, M.; Watts, L.; Booten, S. L.; Graham, M.; McKay, R.; Subramaniam, A.; Propp, S.; Lollo, B. A.; Freier, S.; Bennett, C. F.; Bhanot, S.; Monia, B. P. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell. Metab., 2006, 3(2), 87-98.
51. Ramirez, C. M.; Davalos, A.; Goedeke, L.; Salerno, A. G.; Warrier, N.; Cirera-Salinas, D.; Suarez, Y.; Fernandez-Hernando, C. MicroRNA-758 regulates cholesterol efflux through posttranscriptional repression of ATP-binding cassette transporter A1. Arterioscler. Thromb. Vasc. Biol., 2011, 31(11), 2707-2714.
52. Rayner, K. J.; Suarez, Y.; Davalos, A.; Parathath, S.; Fitzgerald, M. L.; Tamehiro, N.; Fisher, E. A.; Moore, K. J.; Fernandez-Hernando, C. MiR-33 contributes to the regulation of cholesterol homeostasis. Science, 2010, 328(5985), 1570-1573.
53. Ross, R. Atherosclerosis--an inflammatory disease. N. Engl. J. Med., 1999, 340(2), 115-126.
54. Tousoulis, D.; Siasos, G.; Maniatis, K.; Oikonomou, E.; Kioufis, S.; Zaromitidou, M.; Paraskevopoulos, T.; Michalea, S.; Kollia, C.; Miliou, A.; Kokkou, E.; Papavassiliou, A. G.; Stefanadis, C. Serum osteoprotegerin and osteopontin levels are associated with arterial stiffness and the presence and severity of coronary artery disease. Int. J. Cardiol., 2012.
55. Tousoulis, D.; Zisimos, K.; Antoniades, C.; Stefanadi, E.; Siasos, G.; Tsioufis, C.; Papageorgiou, N.; Vavouranakis, E.; Vlachopoulos, C.; Stefanadis, C. Oxidative stress and inflammatory process in patients with atrial fibrillation: the role of left atrium distension. Int. J. Cardiol., 2009, 136(3), 258-262.
56. Stefanadi, E.; Tousoulis, D.; Androulakis, E. S.; Papageorgiou, N.; Charakida, M.; Siasos, G.; Tsioufis, C.; Stefanadis, C. Inflammatory markers in essential hypertension: potential clinical implications. Curr. Vasc. Pharmacol., 2010, 8(4), 509-516.
57. Siasos, G.; Tousoulis, D.; Siasou, Z.; Stefanadis, C.; Papavassiliou, A. G. Shear stress, protein kinases and atherosclerosis. Curr. Med. Chem., 2007, 14(14), 1567-1572.
58. Kampoli, A. M.; Tousoulis, D.; Antoniades, C.; Siasos, G.; Stefanadis, C. Biomarkers of premature atherosclerosis. Trends Mol. Med., 2009, 15(7), 323-332.
59. Ho, P. C.; Chang, K. C.; Chuang, Y. S.; Wei, L. N. Cholesterol regulation of receptor-interacting protein 140 via microRNA-33 in inflammatory cytokine production. FASEB J., 2011, 25(5), 1758-1766.
60. Kim, H. S.; Xiao, C.; Wang, R. H.; Lahusen, T.; Xu, X.; Vassilopoulos, A.; Vazquez-Ortiz, G.; Jeong, W. I.; Park, O.; Ki, S. H.; Gao, B.; Deng, C. X. Hepatic-specific disruption of SIRT6 in mice results in fatty liver formation due to enhanced glycolysis and triglyceride synthesis. Cell Metab., 2010, 12(3), 224-236.
61. Kawahara, T. L.; Rapicavoli, N. A.; Wu, A. R.; Qu, K.; Quake, S. R.; Chang, H. Y. Dynamic chromatin localization of Sirt6 shapes stress-and aging-related transcriptional networks. PLoS. Genet., 2011, 7(6), e1002153.
62. Harris, T. A.; Yamakuchi, M.; Ferlito, M.; Mendell, J. T.; Lowenstein, C. J. MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proc. Natl. Acad. Sci. U. S. A., 2008, 105(5), 1516-1521.
63. Chen, K. C.; Hank Juo, S. H. MicroRNAs in atherosclerosis. Kaohsiung J. Med. Sci., 2012, 28(12), 631-640.
64. Fang, Y.; Shi, C.; Manduchi, E.; Civelek, M.; Davies, P. F. MicroRNA-10a regulation of proinflammatory phenotype in athero-susceptible endothelium in vivo and in vitro. Proc. Natl. Acad. Sci. U. S. A., 2010, 107(30), 13450-13455.
65. Ni, C. W.; Qiu, H.; Jo, H. MicroRNA-663 upregulated by oscillatory shear stress plays a role in inflammatory response of endothelial cells. Am. J. Physiol. Heart Circ. Physiol., 2011, 300(5), H1762-1769.
66. Teng, G.; Papavasiliou, F. N. Shhh! Silencing by microRNA-155. Philos Trans R Soc Lond. B. Biol. Sci., 2009, 364(1517), 631-637.
67. Yamakuchi, M. MicroRNAs in Vascular Biology. Int. J. Vasc. Med., 2012, 2012, 794898.
68. Qin, B.; Yang, H.; Xiao, B. Role of microRNAs in endothelial inflammation and senescence. Mol. Biol. Rep., 2012, 39(4), 4509-4518.
69. Zernecke, A.; Bidzhekov, K.; Noels, H.; Shagdarsuren, E.; Gan, L.; Denecke, B.; Hristov, M.; Koppel, T.; Jahantigh, M. N.; Lutgens, E.; Wang, S.; Olson, E. N.; Schober, A.; Weber, C. Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci. Signal, 2009, 2(100), ra81.
70. Poliseno, L.; Tuccoli, A.; Mariani, L.; Evangelista, M.; Citti, L.; Woods, K.; Mercatanti, A.; Hammond, S.; Rainaldi, G. MicroRNAs modulate the angiogenic properties of HUVECs. Blood, 2006, 108(9), 3068-3071.
71. Suarez, Y.; Fernandez-Hernando, C.; Pober, J. S.; Sessa, W. C. Dicer dependent microRNAs regulate gene expression and functions in human endothelial cells. Circ. Res., 2007, 100(8), 1164-1173.
72. Magenta, A.; Cencioni, C.; Fasanaro, P.; Zaccagnini, G.; Greco, S.; Sarra-Ferraris, G.; Antonini, A.; Martelli, F.; Capogrossi, M. C. miR-200c is upregulated by oxidative stress and induces endothelial cell apoptosis and senescence via ZEB1 inhibition. Cell Death Differ., 2011, 18(10), 1628-1639.
73. Chan, Y. C.; Khanna, S.; Roy, S.; Sen, C. K. miR-200b targets Ets-1 and is down-regulated by hypoxia to induce angiogenic response of endothelial cells. J. Biol. Chem., 2011, 286(3), 2047-2056.
74. Sriram, V.; Patterson, C. Cell cycle in vasculoproliferative diseases: potential interventions and routes of delivery. Circulation, 2001, 103(19), 2414-2419.
75. Mercer, J.; Bennett, M. The role of p53 in atherosclerosis. Cell Cycle, 2006, 5(17), 1907-1909.
76. Cirera-Salinas, D.; Pauta, M.; Allen, R. M.; Salerno, A. G.; Ramirez, C. M.; Chamorro-Jorganes, A.; Wanschel, A. C.; Lasuncion, M. A.; Morales-Ruiz, M.; Suarez, Y.; Baldan, A.; Esplugues, E.; Fernandez-Hernando, C. Mir-33 regulates cell proliferation and cell cycle progression. Cell Cycle, 2012, 11(5), 922-933.
77. Thomas, M.; Lange-Grunweller, K.; Weirauch, U.; Gutsch, D.; Aigner, A.; Grunweller, A.; Hartmann, R. K. The proto-oncogene Pim-1 is a target of miR-33a. Oncogene, 2012, 31(7), 918-928.
78. Katakami, N.; Kaneto, H.; Hao, H.; Umayahara, Y.; Fujitani, Y.; Sakamoto, K.; Gorogawa, S.; Yasuda, T.; Kawamori, D.; Kajimoto, Y.; Matsuhisa, M.; Yutani, C.; Hori, M.; Yamasaki, Y. Role of pim-1 in smooth muscle cell proliferation. J. Biol. Chem., 2004, 279(52), 54742-54749.
79. Takwi, A. A.; Li, Y.; Becker Buscaglia, L. E.; Zhang, J.; Choudhury, S.; Park, A. K.; Liu, M.; Young, K. H.; Park, W. Y.; Martin, R. C. A statin-regulated microRNA represses human c-Myc expression and function. EMBO Mol. Med., 2012, 4(9), 896-909.
80. Blandino, G.; Valerio, M.; Cioce, M.; Mori, F.; Casadei, L.; Pulito, C.; Sacconi, A.; Biagioni, F.; Cortese, G.; Galanti, S.; Manetti, C.; Citro, G.; Muti, P.; Strano, S. Metformin elicits anticancer effects through the sequential modulation of DICER and c-MYC. Nat. Commun., 2012, 3, 865.
81. Napoli, C.; Lerman, L. O.; de Nigris, F.; Sica, V. c-Myc oncoprotein: a dual pathogenic role in neoplasia and cardiovascular diseases? Neoplasia, 2002, 4(3), 185-190.
82. Quintavalle, M.; Condorelli, G.; Elia, L. Arterial remodeling and atherosclerosis: miRNAs involvement. Vascul. Pharmacol., 2011, 55(4), 106-110.
83. Wang, M.; Li, W.; Chang, G. Q.; Ye, C. S.; Ou, J. S.; Li, X. X.; Liu, Y.; Cheang, T. Y.; Huang, X. L.; Wang, S. M. MicroRNA-21 regulates vascular smooth muscle cell function via targeting tropomyosin 1 in arteriosclerosis obliterans of lower extremities. Arterioscler. Thromb. Vasc. Biol., 2011, 31(9), 2044-2053.
84. Davis, B. N.; Hilyard, A. C.; Lagna, G.; Hata, A. SMAD proteins control DROSHA-mediated microRNA maturation. Nature, 2008, 454(7200), 56-61.
85. Sarkar, J.; Gou, D.; Turaka, P.; Viktorova, E.; Ramchandran, R.; Raj, J. U. MicroRNA-21 plays a role in hypoxia-mediated pulmonary artery smooth muscle cell proliferation and migration. Am. J. Physiol. Lung Cell Mol. Physiol., 2010, 299(6), L861-871.
86. Leeper, N. J.; Raiesdana, A.; Kojima, Y.; Chun, H. J.; Azuma, J.; Maegdefessel, L.; Kundu, R. K.; Quertermous, T.; Tsao, P. S.; Spin, J. M. MicroRNA-26a is a novel regulator of vascular smooth muscle cell function. J. Cell Physiol., 2011, 226(4), 1035-1043.
87. Huang, H.; Xie, C.; Sun, X.; Ritchie, R. P.; Zhang, J.; Chen, Y. E. miR-10a contributes to retinoid acid-induced smooth muscle cell differentiation. J. Biol. Chem., 2010, 285(13), 9383-9389.
88. Esau, C.; Kang, X.; Peralta, E.; Hanson, E.; Marcusson, E. G.; Ravichandran, L. V.; Sun, Y.; Koo, S.; Perera, R. J.; Jain, R.; Dean, N. M.; Freier, S. M.; Bennett, C. F.; Lollo, B.; Griffey, R. MicroRNA-143 regulates adipocyte differentiation. J. Biol. Chem., 2004, 279(50), 52361-52365.
89. Rao, P. K.; Toyama, Y.; Chiang, H. R.; Gupta, S.; Bauer, M.; Medvid, R.; Reinhardt, F.; Liao, R.; Krieger, M.; Jaenisch, R.; Lodish, H. F.; Blelloch, R. Loss of cardiac microRNA-mediated regulation leads to dilated cardiomyopathy and heart failure. Circ. Res., 2009, 105(6), 585-594.
90. Quintavalle, M.; Elia, L.; Condorelli, G.; Courtneidge, S. A. MicroRNA control of podosome formation in vascular smooth muscle cells in vivo and in vitro. J. Cell. Biol., 2010, 189(1), 13-22.
91. Cordes, K. R.; Sheehy, N. T.; White, M. P.; Berry, E. C.; Morton, S. U.; Muth, A. N.; Lee, T. H.; Miano, J. M.; Ivey, K. N.; Srivastava, D. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature, 2009, 460(7256), 705-710.
92. Ait-Oufella, H.; Taleb, S.; Mallat, Z.; Tedgui, A. Recent advances on the role of cytokines in atherosclerosis. Arterioscler. Thromb. Vasc. Biol., 2011, 31(5), 969-979.
93. Xin, M.; Small, E. M.; Sutherland, L. B.; Qi, X.; McAnally, J.; Plato, C. F.; Richardson, J. A.; Bassel-Duby, R.; Olson, E. N. MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury. Genes Dev., 2009, 23(18), 2166-2178.
94. Liu, W.; Zi, M.; Jin, J.; Prehar, S.; Oceandy, D.; Kimura, T. E.; Lei, M.; Neyses, L.; Weston, A. H.; Cartwright, E. J.; Wang, X. Cardiac-specific deletion of mkk4 reveals its role in pathological hypertrophic remodeling but not in physiological cardiac growth. Circ. Res., 2009, 104(7), 905-914.
95. le Sage, C.; Nagel, R.; Egan, D. A.; Schrier, M.; Mesman, E.; Mangiola, A.; Anile, C.; Maira, G.; Mercatelli, N.; Ciafre, S. A.; Farace, M. G.; Agami, R. Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. EMBO J., 2007, 26(15), 3699-3708.
96. Zhang, Q.; Kandic, I.; Kutryk, M. J. Dysregulation of angiogenesisrelated microRNAs in endothelial progenitor cells from patients with coronary artery disease. Biochem. Biophys. Res. Commun., 2011, 405(1), 42-46.
97. Latronico, M. V.; Catalucci, D.; Condorelli, G. Emerging role of microRNAs in cardiovascular biology. Circ. Res., 2007, 101(12), 1225-1236.
98. Takaya, T.; Ono, K.; Kawamura, T.; Takanabe, R.; Kaichi, S.; Morimoto, T.; Wada, H.; Kita, T.; Shimatsu, A.; Hasegawa, K. MicroRNA-1 and MicroRNA-133 in spontaneous myocardial differentiation of mouse embryonic stem cells. Circ. J., 2009, 73(8), 1492-1497.
99. Chen, J.; Yin, H.; Jiang, Y.; Radhakrishnan, S. K.; Huang, Z. P.; Li, J.; Shi, Z.; Kilsdonk, E. P.; Gui, Y.; Wang, D. Z.; Zheng, X. L. Induction of microRNA-1 by myocardin in smooth muscle cells inhibits cell proliferation. Arterioscler. Thromb. Vasc. Biol., 2011, 31(2), 368-375.
100. Xie, C.; Huang, H.; Sun, X.; Guo, Y.; Hamblin, M.; Ritchie, R. P.; Garcia-Barrio, M. T.; Zhang, J.; Chen, Y. E. MicroRNA-1 regulates smooth muscle cell differentiation by repressing Kruppellike factor 4. Stem Cells Dev., 2011, 20(2), 205-210.
101. Torella, D.; Iaconetti, C.; Catalucci, D.; Ellison, G. M.; Leone, A.; Waring, C. D.; Bochicchio, A.; Vicinanza, C.; Aquila, I.; Curcio, A.; Condorelli, G.; Indolfi, C. MicroRNA-133 controls vascular smooth muscle cell phenotypic switch in vitro and vascular remodeling in vivo. Circ. Res., 2011, 109(8), 880-893.
102. Chen, L. J.; Lim, S. H.; Yeh, Y. T.; Lien, S. C.; Chiu, J. J. Roles of microRNAs in atherosclerosis and restenosis. J. Biomed. Sci., 2012, 19(1), 79.
103. Li, Y. X.; Liu, D. Q.; Zheng, C.; Zheng, S. Q.; Liu, M.; Li, X.; Tang, H. miR-200a modulate HUVECs viability and migration. IUBMB Life, 2011, 63(7), 553-559.
104. Wang, X. H.; Qian, R. Z.; Zhang, W.; Chen, S. F.; Jin, H. M.; Hu, R. M. MicroRNA-320 expression in myocardial microvascular endothelial cells and its relationship with insulin-like growth factor-1 in type 2 diabetic rats. Clin. Exp. Pharmacol. Physiol., 2009, 36(2), 181-188.
105. Tousoulis, D.; Siasos, G.; Zaromitidou, M.; Oikonomou, E.; Maniatis, K.; Kioufis, S.; Kokkou, E.; Papavassiliou, A. G.; Stefanadis, C. The impact of CYP2C19 genotype on cardiovascular events and platelet reactivity in patients with coronary artery disease receiving clopidogrel. Int. J. Cardiol., 2013.
106. Papageorgiou, N.; Tousoulis, D.; Siasos, G.; Stefanadis, C. Is fibrinogen a marker of inflammation in coronary artery disease? Hellenic J. Cardiol., 2010, 51(1), 1-9.
107. Landry, P.; Plante, I.; Ouellet, D. L.; Perron, M. P.; Rousseau, G.; Provost, P. Existence of a microRNA pathway in anucleate platelets. Nat. Struct. Mol. Biol., 2009, 16(9), 961-966.
108. Gatsiou, A.; Boeckel, J. N.; Randriamboavonjy, V.; Stellos, K. MicroRNAs in platelet biogenesis and function: implications in vascular homeostasis and inflammation. Curr. Vasc. Pharmacol., 2012, 10(5), 524-531.
109. Stakos, D. A.; Gatsiou, A.; Stamatelopoulos, K.; Tselepis, A. D.; Stellos, K. Platelet microRNAs: From platelet biology to possible disease biomarkers and therapeutic targets. Platelets, 2012.
110. Dangelmaier, C.; Jin, J.; Smith, J. B.; Kunapuli, S. P. Potentiation of thromboxane A2-induced platelet secretion by Gi signaling through the phosphoinositide-3 kinase pathway. Thromb. Haemost., 2001, 85(2), 341-348.
111. Jin, J.; Quinton, T. M.; Zhang, J.; Rittenhouse, S. E.; Kunapuli, S. P. Adenosine diphosphate (ADP)-induced thromboxane A(2) generation in human platelets requires coordinated signaling through integrin alpha(IIb)beta(3) and ADP receptors. Blood, 2002, 99(1), 193-198.
112. Tan, M. H.; Sun, Z.; Opitz, S. L.; Schmidt, T. E.; Peters, J. H.; George, E. L. Deletion of the alternatively spliced fibronectin EIIIA domain in mice reduces atherosclerosis. Blood, 2004, 104(1), 11-18.
113. Matuskova, J.; Chauhan, A. K.; Cambien, B.; Astrof, S.; Dole, V. S.; Piffath, C. L.; Hynes, R. O.; Wagner, D. D. Decreased plasma fibronectin leads to delayed thrombus growth in injured arterioles. Arterioscler. Thromb. Vasc. Biol., 2006, 26(6), 1391-1396.
114. Ni, H.; Yuen, P. S.; Papalia, J. M.; Trevithick, J. E.; Sakai, T.; Fassler, R.; Hynes, R. O.; Wagner, D. D. Plasma fibronectin promotes thrombus growth and stability in injured arterioles. Proc. Natl. Acad. Sci. U S A, 2003, 100(5), 2415-2419.
115. Cho, J.; Mosher, D. F. Impact of fibronectin assembly on platelet thrombus formation in response to type I collagen and von Willebrand factor. Blood, 2006, 108(7), 2229-2236.
116. Shan, S. W.; Lee, D. Y.; Deng, Z.; Shatseva, T.; Jeyapalan, Z.; Du, W. W.; Zhang, Y.; Xuan, J. W.; Yee, S. P.; Siragam, V.; Yang, B. B. MicroRNA MiR-17 retards tissue growth and represses fibronectin expression. Nat. Cell Biol., 2009, 11(8), 1031-1038.
117. Cheresh, D. A.; Berliner, S. A.; Vicente, V.; Ruggeri, Z. M. Recognition of distinct adhesive sites on fibrinogen by related integrins on platelets and endothelial cells. Cell, 1989, 58(5), 945-953.
118. Chen, C. S.; Hawiger, J. Reactivity of synthetic peptide analogs of adhesive proteins in regard to the interaction of human endothelial cells with extracellular matrix. Blood, 1991, 77(10), 2200-2206.
119. Mosesson, M. W.; Siebenlist, K. R.; Meh, D. A. The structure and biological features of fibrinogen and fibrin. Ann. N. Y. Acad. Sci., 2001, 936, 11-30.
120. Fort, A.; Borel, C.; Migliavacca, E.; Antonarakis, S. E.; Fish, R. J.; Neerman-Arbez, M. Regulation of fibrinogen production by microRNAs. Blood, 2010, 116(14), 2608-2615.
121. Ren, Q.; Barber, H. K.; Crawford, G. L.; Karim, Z. A.; Zhao, C.; Choi, W.; Wang, C. C.; Hong, W.; Whiteheart, S. W. Endobrevin/VAMP-8 is the primary v-SNARE for the platelet release reaction. Mol. Biol. Cell, 2007, 18(1), 24-33.
122. Schmidt, M.; Paes, K.; De Maziere, A.; Smyczek, T.; Yang, S.; Gray, A.; French, D.; Kasman, I.; Klumperman, J.; Rice, D. S.; Ye, W. EGFL7 regulates the collective migration of endothelial cells by restricting their spatial distribution. Development, 2007, 134(16), 2913-2923.
123. Kuhnert, F.; Mancuso, M. R.; Hampton, J.; Stankunas, K.; Asano, T.; Chen, C. Z.; Kuo, C. J. Attribution of vascular phenotypes of the murine Egfl7 locus to the microRNA miR-126. Development, 2008, 135(24), 3989-3993.
124. Wang, S.; Aurora, A. B.; Johnson, B. A.; Qi, X.; McAnally, J.; Hill, J. A.; Richardson, J. A.; Bassel-Duby, R.; Olson, E. N. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev. Cell, 2008, 15(2), 261-271.
125. Chen, Y.; Gorski, D. H. Regulation of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5. Blood, 2008, 111(3), 1217-1226.
126. Lee, D. Y.; Deng, Z.; Wang, C. H.; Yang, B. B. MicroRNA-378 promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expression. Proc. Natl. Acad. Sci. U. S. A., 2007, 104(51), 20350-20355.
127. Dews, M.; Homayouni, A.; Yu, D.; Murphy, D.; Sevignani, C.; Wentzel, E.; Furth, E. E.; Lee, W. M.; Enders, G. H.; Mendell, J. T.; Thomas-Tikhonenko, A. Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nat. Genet., 2006, 38(9), 1060-1065.
128. Kuehbacher, A.; Urbich, C.; Zeiher, A. M.; Dimmeler, S. Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis. Circ. Res., 2007, 101(1), 59-68.
129. Suarez, Y.; Fernandez-Hernando, C.; Yu, J.; Gerber, S. A.; Harrison, K. D.; Pober, J. S.; Iruela-Arispe, M. L.; Merkenschlager, M.; Sessa, W. C. Dicer-dependent endothelial microRNAs are necessary for postnatal angiogenesis. Proc. Natl. Acad. Sci. U. S. A., 2008, 105(37), 14082-14087.
130. Bonauer, A.; Carmona, G.; Iwasaki, M.; Mione, M.; Koyanagi, M.; Fischer, A.; Burchfield, J.; Fox, H.; Doebele, C.; Ohtani, K.; Chavakis, E.; Potente, M.; Tjwa, M.; Urbich, C.; Zeiher, A. M.; Dimmeler, S. MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science, 2009, 324(5935), 1710-1713.
131. Choi, Y. C.; Yoon, S.; Jeong, Y.; Yoon, J.; Baek, K. Regulation of vascular endothelial growth factor signaling by miR-200b. Mol. Cells, 2011, 32(1), 77-82.
132. Care, A.; Catalucci, D.; Felicetti, F.; Bonci, D.; Addario, A.; Gallo, P.; Bang, M. L.; Segnalini, P.; Gu, Y.; Dalton, N. D.; Elia, L.; Latronico, M. V.; Hoydal, M.; Autore, C.; Russo, M. A.; Dorn, G. W. 2nd; Ellingsen, O.; Ruiz-Lozano, P.; Peterson, K. L.; Croce, C. M.; Peschle, C.; Condorelli, G. MicroRNA-133 controls cardiac hypertrophy. Nat. Med., 2007, 13(5), 613-618.
133. Guduric-Fuchs, J.; O'Connor, A.; Cullen, A.; Harwood, L.; Medina, R. J.; O'Neill, C. L.; Stitt, A. W.; Curtis, T. M.; Simpson, D. A. Deep sequencing reveals predominant expression of miR-21 amongst the small non-coding RNAs in retinal microvascular endothelial cells. J. Cell Biochem., 2012, 113(6), 2098-2111.
134. Vanhoutte, P. M. Endothelial dysfunction: the first step toward coronary arteriosclerosis. Circ. J., 2009, 73(4), 595-601.
135. Siasos, G.; Tousoulis, D.; Oikonomou, E.; Zaromitidou, M.; Verveniotis, A.; Plastiras, A.; Kioufis, S.; Maniatis, K.; Miliou, A.; Siasou, Z.; Stefanadis, C.; Papavassiliou, A. G. Effects of omega-3 fatty acids on endothelial function, arterial wall properties, inflammatory and fibrinolytic status in smokers: A cross over study. Int. J. Cardiol., 2011.
136. Tousoulis, D.; Siasos, G.; Oikonomou, E.; Stougianos, P.; Papageorgiou, N.; Papavassiliou, A. G.; Stefanadis, C. Asymmetric dimethylarginine (ADMA): is really a biomarker for cardiovascular prognosis? Int. J. Cardiol., 2011, 153(2), 123-125.
137. Siasos, G.; Tousoulis, D.; Vlachopoulos, C.; Antoniades, C.; Stefanadi, E.; Ioakeimidis, N.; Andreou, I.; Zisimos, K.; Papavassiliou, A. G.; Stefanadis, C. Short-term treatment with Larginine prevents the smoking-induced impairment of endothelial function and vascular elastic properties in young individuals. Int. J Cardiol., 2008, 126(3), 394-399.
138. Siasos, G.; Tousoulis, D.; Vlachopoulos, C.; Antoniades, C.; Stefanadi, E.; Ioakeimidis, N.; Zisimos, K.; Siasou, Z.; Papavassiliou, A. G.; Stefanadis, C. The impact of oral L-arginine supplementation on acute smoking-induced endothelial injury and arterial performance. Am. J. Hypertens., 2009, 22(6), 586-592.
139. Tousoulis, D.; Boger, R. H.; Antoniades, C.; Siasos, G.; Stefanadi, E.; Stefanadis, C. Mechanisms of disease: L-arginine in coronary atherosclerosis--a clinical perspective. Nat. Clin. Pract. Cardiovasc. Med., 2007, 4(5), 274-283.
140. Giannotti, G.; Landmesser, U. Endothelial dysfunction as an early sign of atherosclerosis. Herz, 2007, 32(7), 568-572.
141. Davignon, J.; Ganz, P. Role of endothelial dysfunction in atherosclerosis. Circulation, 2004, 109(23 Suppl 1), 27-32.
142. Siasos, G.; Tousoulis, D.; Antoniades, C.; Stefanadi, E.; Stefanadis, C. L-Arginine, the substrate for NO synthesis: an alternative treatment for premature atherosclerosis? Int. J. Cardiol., 2007, 116(3), 300-308.
143. Dong, S.; Cheng, Y.; Yang, J.; Li, J.; Liu, X.; Wang, X.; Wang, D.; Krall, T. J.; Delphin, E. S.; Zhang, C. MicroRNA expression signature and the role of microRNA-21 in the early phase of acute myocardial infarction. J. Biol. Chem., 2009, 284(43), 29514-29525.
144. Zhou, J.; Wang, K. C.; Wu, W.; Subramaniam, S.; Shyy, J. Y.; Chiu, J. J.; Li, J. Y.; Chien, S. MicroRNA-21 targets peroxisome proliferators-activated receptor-alpha in an autoregulatory loop to modulate flow-induced endothelial inflammation. Proc. Natl. Acad. Sci. U. S. A., 2011, 108(25), 10355-10360.
145. Menghini, R.; Casagrande, V.; Cardellini, M.; Martelli, E.; Terrinoni, A.; Amati, F.; Vasa-Nicotera, M.; Ippoliti, A.; Novelli, G.; Melino, G.; Lauro, R.; Federici, M. MicroRNA 217 modulates endothelial cell senescence via silent information regulator 1. Circulation, 2009, 120(15), 1524-1532.
146. Potente, M.; Dimmeler, S. Emerging roles of SIRT1 in vascular endothelial homeostasis. Cell Cycle, 2008, 7(14), 2117-2122.
147. Ota, H.; Akishita, M.; Eto, M.; Iijima, K.; Kaneki, M.; Ouchi, Y. Sirt1 modulates premature senescence-like phenotype in human endothelial cells. J. Mol. Cell Cardiol., 2007, 43(5), 571-579.
148. Ito, T.; Yagi, S.; Yamakuchi, M. MicroRNA-34a regulation of endothelial senescence. Biochem. Biophys. Res. Commun., 2010, 398(4), 735-740.
149. Tousoulis, D.; Siasos, G.; Maniatis, K.; Oikonomou, E.; Vlasis, K.; Papavassiliou, A. G.; Stefanadis, C. Novel biomarkers assessing the calcium deposition in coronary artery disease. Curr. Med. Chem., 2012, 19(6), 901-920.
150. Forrest, A. R.; Kanamori-Katayama, M.; Tomaru, Y.; Lassmann, T.; Ninomiya, N.; Takahashi, Y.; de Hoon, M. J.; Kubosaki, A.; Kaiho, A.; Suzuki, M.; Yasuda, J.; Kawai, J.; Hayashizaki, Y.; Hume, D. A.; Suzuki, H. Induction of microRNAs, mir-155, mir-222, mir-424 and mir-503, promotes monocytic differentiation through combinatorial regulation. Leukemia, 2010, 24(2), 460-466.
151. Chen, T.; Huang, Z.; Wang, L.; Wang, Y.; Wu, F.; Meng, S.; Wang, C. MicroRNA-125a-5p partly regulates the inflammatory response, lipid uptake, and ORP9 expression in oxLDL-stimulated monocyte/macrophages. Cardiovasc. Res., 2009, 83(1), 131-139.
152. Chen, T.; Li, Z.; Jing, T.; Zhu, W.; Ge, J.; Zheng, X.; Pan, X.; Yan, H.; Zhu, J. MicroRNA-146a regulates the maturation process and pro-inflammatory cytokine secretion by targeting CD40L in oxLDL-stimulated dendritic cells. FEBS Lett., 2011, 585(3), 567-573.
153. Yang, K.; He, Y. S.; Wang, X. Q.; Lu, L.; Chen, Q. J.; Liu, J.; Sun, Z.; Shen, W. F. MiR-146a inhibits oxidized low-density lipoprotein-induced lipid accumulation and inflammatory response via targeting toll-like receptor 4. FEBS Lett., 2011, 585(6), 854-860.
154. Thum, T.; Gross, C.; Fiedler, J.; Fischer, T.; Kissler, S.; Bussen, M.; Galuppo, P.; Just, S.; Rottbauer, W.; Frantz, S.; Castoldi, M.; Soutschek, J.; Koteliansky, V.; Rosenwald, A.; Basson, M. A.; Licht, J. D.; Pena, J. T.; Rouhanifard, S. H.; Muckenthaler, M. U.; Tuschl, T.; Martin, G. R.; Bauersachs, J.; Engelhardt, S. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature, 2008, 456(7224), 980-984.
155. Liu, Y.; Taylor, N. E.; Lu, L.; Usa, K.; Cowley, A. W. Jr.; Ferreri, N. R.; Yeo, N. C.; Liang, M. Renal medullary microRNAs in Dahl salt-sensitive rats: miR-29b regulates several collagens and related genes. Hypertension, 2010, 55(4), 974-982.
156. Kato, M.; Zhang, J.; Wang, M.; Lanting, L.; Yuan, H.; Rossi, J. J.; Natarajan, R. MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors. Proc. Natl. Acad. Sci. U. S. A., 2007, 104(9), 3432-3437.
157. Cipollone, F.; Fazia, M.; Mezzetti, A. Novel determinants of plaque instability. J. Thromb. Haemost., 2005, 3(9), 1962-1975.
158. Siasos, G.; Tousoulis, D.; Kioufis, S.; Oikonomou, E.; Siasou, Z.; Limperi, M.; Papavassiliou, A. G.; Stefanadis, C. Inflammatory mechanisms in atherosclerosis: the impact of matrix metalloproteinases. Curr. Top. Med. Chem., 2012, 12(10), 1132-1148.
159. Papageorgiou, N.; Tousoulis, D.; Hatzis, G.; Briasoulis, A.; Androulakis, E.; Giolis, A.; Siasos, G.; Latsios, G.; Vogiatzi, G.; Tentolouris, C.; Stefanadis, C. Genetic variability of matrix metalloproteinase genes in cardiovascular disease. Curr. Top. Med. Chem., 2012, 12(10), 1206-1213.
160. Yamasaki, K.; Nakasa, T.; Miyaki, S.; Ishikawa, M.; Deie, M.; Adachi, N.; Yasunaga, Y.; Asahara, H.; Ochi, M. Expression of MicroRNA-146a in osteoarthritis cartilage. Arthritis Rheum., 2009, 60(4), 1035-1041.
161. Taganov, K. D.; Boldin, M. P.; Chang, K. J.; Baltimore, D. NFkappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. U. S. A., 2006, 103(33), 12481-12486.
162. Mishra, P. K.; Tyagi, N.; Kumar, M.; Tyagi, S. C. MicroRNAs as a therapeutic target for cardiovascular diseases. J. Cell Mol. Med., 2009, 13(4), 778-789.
163. Tan, K. S.; Armugam, A.; Sepramaniam, S.; Lim, K. Y.; Setyowati, K. D.; Wang, C. W.; Jeyaseelan, K. Expression profile of MicroRNAs in young stroke patients. PLoS. One, 2009, 4(11), e7689.
164. Fichtlscherer, S.; De Rosa, S.; Fox, H.; Schwietz, T.; Fischer, A.; Liebetrau, C.; Weber, M.; Hamm, C. W.; Roxe, T.; Muller-Ardogan, M.; Bonauer, A.; Zeiher, A. M.; Dimmeler, S. Circulating microRNAs in patients with coronary artery disease. Circ. Res., 2010, 107(5), 677-684.
165. Siasos, G.; Tousoulis, D.; Oikonomou, E.; Zaromitidou, M.; Stefanadis, C.; Papavassiliou, A. G. Inflammatory markers in hyperlipidemia: from experimental models to clinical practice. Curr Pharm Des, 2011, 17(37), 4132-4146.
166. Navab, M.; Reddy, S. T.; Van Lenten, B. J.; Fogelman, A. M. HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms. Nat Rev Cardiol, 2011, 8(4), 222-232.
167. Rayner, K. J.; Esau, C. C.; Hussain, F. N.; McDaniel, A. L.; Marshall, S. M.; van Gils, J. M.; Ray, T. D.; Sheedy, F. J.; Goedeke, L.; Liu, X.; Khatsenko, O. G.; Kaimal, V.; Lees, C. J.; Fernandez-Hernando, C.; Fisher, E. A.; Temel, R. E.; Moore, K. J. Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides. Nature, 2011, 478(7369), 404-407.
168. Gerin, I.; Clerbaux, L. A.; Haumont, O.; Lanthier, N.; Das, A. K.; Burant, C. F.; Leclercq, I. A.; MacDougald, O. A.; Bommer, G. T. Expression of miR-33 from an SREBP2 intron inhibits cholesterol export and fatty acid oxidation. J. Biol. Chem., 2010, 285(44), 33652-33661.
169. Davalos, A.; Goedeke, L.; Smibert, P.; Ramirez, C. M.; Warrier, N. P.; Andreo, U.; Cirera-Salinas, D.; Rayner, K.; Suresh, U.; Pastor-Pareja, J. C.; Esplugues, E.; Fisher, E. A.; Penalva, L. O.; Moore, K. J.; Suarez, Y.; Lai, E. C.; Fernandez-Hernando, C. miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling. Proc. Natl. Acad. Sci. U. S. A., 2011, 108(22), 9232-9237.
170. Hicks, J. A.; Trakooljul, N.; Liu, H. C. Discovery of chicken microRNAs associated with lipogenesis and cell proliferation. Physiol. Genomics, 2010, 41(2), 185-193.
171. Shah, S.; Sanford, U. R.; Vargas, J. C.; Xu, H.; Groen, A.; Paulusma, C. C.; Grenert, J. P.; Pawlikowska, L.; Sen, S.; Elferink, R. P.; Bull, L. N. Strain background modifies phenotypes in the ATP8B1-deficient mouse. PLoS. One, 2010, 5(2), e8984.
172. Marquart, T. J.; Allen, R. M.; Ory, D. S.; Baldan, A. miR-33 links SREBP-2 induction to repression of sterol transporters. Proc. Natl. Acad. Sci. U. S. A., 2010, 107(27), 12228-12232.
173. Najafi-Shoushtari, S. H.; Kristo, F.; Li, Y.; Shioda, T.; Cohen, D. E.; Gerszten, R. E.; Naar, A. M. MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis. Science, 2010, 328(5985), 1566-1569.
174. Krutzfeldt, J.; Rajewsky, N.; Braich, R.; Rajeev, K. G.; Tuschl, T.; Manoharan, M.; Stoffel, M. Silencing of microRNAs in vivo with 'antagomirs'. Nature, 2005, 438(7068), 685-689.
175. Lagos-Quintana, M.; Rauhut, R.; Yalcin, A.; Meyer, J.; Lendeckel, W.; Tuschl, T. Identification of tissue-specific microRNAs from mouse. Curr. Biol., 2002, 12(9), 735-739.
176. Wahrle, S. E.; Jiang, H.; Parsadanian, M.; Kim, J.; Li, A.; Knoten, A.; Jain, S.; Hirsch-Reinshagen, V.; Wellington, C. L.; Bales, K. R.; Paul, S. M.; Holtzman, D. M. Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease. J. Clin. Invest., 2008, 118(2), 671-682.
177. Hirsch-Reinshagen, V.; Zhou, S.; Burgess, B. L.; Bernier, L.; McIsaac, S. A.; Chan, J. Y.; Tansley, G. H.; Cohn, J. S.; Hayden, M. R.; Wellington, C. L. Deficiency of ABCA1 impairs apolipoprotein E metabolism in brain. J. Biol. Chem., 2004, 279(39), 41197-41207.
178. Koldamova, R.; Staufenbiel, M.; Lefterov, I. Lack of ABCA1 considerably decreases brain ApoE level and increases amyloid deposition in APP23 mice. J. Biol. Chem., 2005, 280(52), 43224-43235.
179. Asahara, T.; Murohara, T.; Sullivan, A.; Silver, M.; van der Zee, R.; Li, T.; Witzenbichler, B.; Schatteman, G.; Isner, J. M. Isolation of putative progenitor endothelial cells for angiogenesis. Science, 1997, 275(5302), 964-967.
180. Weber, J. A.; Baxter, D. H.; Zhang, S.; Huang, D. Y.; Huang, K. H.; Lee, M. J.; Galas, D. J.; Wang, K. The microRNA spectrum in 12 body fluids. Clin. Chem., 2010, 56(11), 1733-1741.
181. Chen, X.; Ba, Y.; Ma, L.; Cai, X.; Yin, Y.; Wang, K.; Guo, J.; Zhang, Y.; Chen, J.; Guo, X.; Li, Q.; Li, X.; Wang, W.; Wang, J.; Jiang, X.; Xiang, Y.; Xu, C.; Zheng, P.; Zhang, J.; Li, R.; Zhang, H.; Shang, X.; Gong, T.; Ning, G.; Zen, K.; Zhang, C. Y. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res., 2008, 18(10), 997-1006.
182. Edelstein, L. C.; Bray, P. F. Small RNAs as potential platelet therapeutics. Handb. Exp. Pharmacol., 2012(210), 435-445.
183. Yue, J. miRNA and vascular cell movement. Adv. Drug. Deliv. Rev., 2011, 63(8), 616-622.
184. Wahid, F.; Shehzad, A.; Khan, T.; Kim, Y. Y. MicroRNAs: synthesis, mechanism, function, and recent clinical trials. Biochim. Biophys. Acta., 2010, 1803(11), 1231-1243.